Key to Bibby Scientific's strategy for growth is to invest heavily in both r&d and marketing. The company’s aim is to develop a continuous stream of products that deliver real value to the scientist in terms of functionality, connectivity and performance.
Andy Mooney, Bibby Scientific sales director, said the new office in Singapore would help Bibby expand its geographical footprint and work more closely with customers in the region.
‘Deepening our understanding of the Asian market will lead to the development of products aligned to local customer requirements, and our presence will also enable us to provide a higher level of support to both dealers and end users,’ he said.
Bibby Scientific opens sales office in Singapore
Enables laboratory products supplier to build relationships in whole Asian region
You may also like
Trending Articles
-
You need to be a subscriber to read this article.
Click here to find out more.
You may also like
Manufacturing
Lonza appoints Hans Trees as Global Head of Communications
Hans Trees will join Lonza as Global Head of Communications, Senior Vice President and Member of the Extended Executive Committee, effective 1 September 2026. Hans combines deep industry experience with a strong track record in stakeholder engagement, most recently serving as Global Head of External Engagement at Roche
Manufacturing
AlzeCure licenses Alzheimer’s candidate ACD680 to Lilly in deal worth up to $1bn
AlzeCure Pharma has entered a global licensing and collaboration agreement with Eli Lilly for its Alzheimer's disease candidate ACD680, securing a $10m upfront payment and potential milestone payments exceeding $1bn